Physician

Robert Stephen Avilla, D.O.

According to 2025 Medicare claims, Robert Avilla, D.O. (NPI: 1346687225) practices family practice in the Chico, CA market, with the plurality of this provider's patient population coming from Butte, CA. This provider's primary affiliated billing organization is MANGROVE MEDICAL GROUP (NPI: 1326038381; TIN: 946195952) and primary practice location at 95926-3509. Avilla is affiliated with the Achiever Health Care Consultation and Management LLC (ACO ID: A4597), participating under the MSSP model.

Avilla's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,270 traditional Medicare patients, billed 26,963 HCPCS/CPT codes, and received $701,690 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 14,667 prescription claims across 1,129 beneficiaries totaling $1,262,319 in drug costs, led by Ozempic (Semaglutide). DME data shows 692 claims. Open Payments data shows 158 records totaling $2,581. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $46,921 to $701,690. Similarly, Part D prescription costs have risen steadily, from $5,965 to $1,262,319. In contrast, DME billing represents a smaller volume and rose steadily, from $949 to $76,175.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	321	2,427	$46,921
2017	738	6,384	$183,153
2018	982	13,360	$380,596
2019	1,141	16,640	$483,579
2020	1,169	26,451	$817,166
2021	1,061	23,864	$758,340
2022	1,106	23,507	$619,117
2023	1,111	21,647	$564,801
2024	1,270	26,963	$701,690

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	50	341	$5,965
2016	176	635	$14,748
2017	417	2,273	$109,984
2018	586	5,537	$363,493
2019	782	7,902	$574,157
2020	883	12,230	$982,865
2021	809	11,786	$977,892
2022	861	12,134	$995,170
2023	975	12,928	$1,213,569
2024	1,129	14,667	$1,262,319

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	26	$326
2018	32	158	$1,919
2019	73	268	$13,749
2020	129	497	$23,818
2021	175	740	$37,409
2022	233	616	$37,701
2023	246	775	$51,562
2024	219	692	$46,106

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	686	686	$132
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	975	2,180	$61
80053	Blood test, comprehensive group of blood chemicals	737	985	$10
36415	Insertion of needle into vein for collection of blood sample	810	1,237	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	711	902	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	119	4,698	$137,843
Jardiance	Empagliflozin	47	4,230	$77,030
Mounjaro	Tirzepatide	62	1,988	$71,502
Eliquis	Apixaban	67	3,753	$70,315
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	69	3,150	$64,925

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	14	78	$25,296
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	43	$3,180
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	23	49	$2,473
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	31	63	$2,267
A7032	Cushion for use on nasal mask interface, replacement only, each	N	13	24	$2,232

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	158	$2,581	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert Stephen Avilla, D.O.?

Tedicare shows public-source Medicare data for Robert Stephen Avilla, D.O. (NPI 1346687225), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Stephen Avilla, D.O. have ACO affiliation data?

Robert Stephen Avilla, D.O. is shown with ACO affiliation data for Achiever Health Care Consultation and Management LLC (MSSP, ACO ID A4597).

What billing organization is linked to Robert Stephen Avilla, D.O.?

Robert Stephen Avilla, D.O. is linked to MANGROVE MEDICAL GROUP (billing NPI 1326038381) in the available physician profile data.

Does Robert Stephen Avilla, D.O. have Open Payments data?

Robert Stephen Avilla, D.O. has 158 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.